Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity

免疫检查点阻断可诱导肠道菌群移位,从而增强肠外抗肿瘤免疫力。

阅读:4
作者:Yongbin Choi ,Jake N Lichterman ,Laura A Coughlin ,Nicole Poulides ,Wenling Li ,Priscilla Del Valle ,Suzette N Palmer ,Shuheng Gan ,Jiwoong Kim ,Xiaowei Zhan ,Yajing Gao ,Bret M Evers ,Lora V Hooper ,Chandrashekhar Pasare ,Andrew Y Koh

Abstract

Gut microbiota, specifically gut bacteria, are critical for effective immune checkpoint blockade therapy (ICT) for cancer. The mechanisms by which gut microbiota augment extraintestinal anticancer immune responses, however, are largely unknown. Here, we find that ICT induces the translocation of specific endogenous gut bacteria into secondary lymphoid organs and subcutaneous melanoma tumors. Mechanistically, ICT induces lymph node remodeling and dendritic cell (DC) activation, which facilitates the translocation of a selective subset of gut bacteria to extraintestinal tissues to promote optimal antitumor T cell responses in both the tumor-draining lymph nodes (TDLNs) and the primary tumor. Antibiotic treatment results in decreased gut microbiota translocation into mesenteric lymph nodes (MLNs) and TDLNs, diminished DC and effector CD8+ T cell responses, and attenuated responses to ICT. Our findings illuminate a key mechanism by which gut microbiota promote extraintestinal anticancer immunity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。